SEEL
Price:
$0.1865
Market Cap:
$1.30M
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD). Its preclinical programs include SLS-007, an anti-alpha-synuclein peptidic inhibitor to treat patients ...[Read more]
Industry
Biotechnology
IPO Date
1999-04-19
Stock Exchange
NASDAQ
Ticker
SEEL
According to Seelos Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Seelos Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), SEEL's Dividend Yield was at its highest in in the September 2014 quarter at 0%. The Dividend Yield was at its lowest in in the September 2014 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Seelos Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
Year | Dividend Yield | Change |
---|---|---|
2023 | 0% | 0% |
2022 | 0% | 0% |
2021 | 0% | 0% |
2020 | 0% | 0% |
2019 | 0% | 0% |
2018 | 0% | 0% |
2017 | 0% | 0% |
2016 | 0% | 0% |
2015 | 0% | 0% |
2014 | 0% | 0% |
The current Dividend Yield of Seelos Therapeutics, Inc. (SEEL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Seelos Therapeutics, Inc.’s Dividend Yield is less than Atai Life Sciences N.V. (0%), less than Mind Medicine (MindMed) Inc. (0%), less than GH Research PLC (0%), less than Freeline Therapeutics Holdings plc (0%), less than Cybin Inc. (0%), less than Awakn Life Sciences Corp. (0%), less than Pulmatrix, Inc. (0%), less than Capricor Therapeutics, Inc. (0%), less than Akari Therapeutics, Plc (0%), less than Diffusion Pharmaceuticals Inc. (0%), less than Soleno Therapeutics, Inc. (0%), less than Eliem Therapeutics, Inc. (0%), less than Opthea Limited (0%), less than Molecular Partners AG (0%), less than Edgewise Therapeutics, Inc. (0%), less than iTeos Therapeutics, Inc. (0%), less than TRACON Pharmaceuticals, Inc. (0%), less than Histogen Inc. (0%), less than Entera Bio Ltd. (0%), less than Tempest Therapeutics, Inc. (0%), less than Better Therapeutics, Inc. (0%),
Company | Dividend Yield | Market cap |
---|---|---|
0% | $210.12M | |
0% | $516.64M | |
0% | $419.35M | |
0% | $28.28M | |
0% | $149.20M | |
0% | $2.71M | |
0% | $7.45M | |
0% | $143.17M | |
0% | $41.66M | |
0% | $8.98M | |
0% | $2.05B | |
0% | $553.25M | |
0% | $511.67M | |
0% | $172.94M | |
0% | $1.59B | |
0% | $435.71M | |
0% | $204.45K | |
0% | $929.11K | |
0% | $72.65M | |
0% | $34.03M | |
0% | $5.45K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Seelos Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Seelos Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Seelos Therapeutics, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Seelos Therapeutics, Inc. (SEEL)?
What is the highest Dividend Yield for Seelos Therapeutics, Inc. (SEEL)?
What is the 3-year average Dividend Yield for Seelos Therapeutics, Inc. (SEEL)?
What is the 5-year average Dividend Yield for Seelos Therapeutics, Inc. (SEEL)?
How does the current Dividend Yield for Seelos Therapeutics, Inc. (SEEL) compare to its historical average?